psyllium

Brand: Metamucil, Konsyl

Prototype Drug
Drug Class: bulk-forming laxative / fiber supplement
Drug Family: GI agent
Subclass: soluble dietary fiber
Organ Systems: gastrointestinalcardiovascular

Mechanism of Action

Absorbs water in the GI tract to form a viscous gel that increases fecal bulk, stimulates peristalsis, and softens stool. Also binds bile acids in the intestinal lumen, reducing their reabsorption and lowering LDL cholesterol through a mechanism similar to bile acid sequestrants.

GI tract (physical bulk mechanism)bile acid resins (cholesterol lowering)

Indications

  • constipation
  • irritable bowel syndrome (diarrhea-predominant)
  • hypercholesterolemia (adjunct)
  • prevention of hemorrhoid recurrence

Contraindications

  • intestinal obstruction
  • difficulty swallowing (must be taken with adequate fluid)
  • phenylketonuria (some products contain aspartame)

Adverse Effects

Common

  • bloating
  • flatulence
  • abdominal cramping (initial use)

Serious

  • esophageal or GI obstruction if taken without sufficient water
  • anaphylaxis (rare, psyllium allergy)

Pharmacokinetics (ADME)

Absorption not absorbed; acts entirely within GI lumen
Distribution none (not systemically absorbed)
Metabolism fermented by colonic bacteria
Excretion fecal
Half-life not applicable
Onset 12–72 hours
Peak 1–3 days
Duration varies
Protein Binding none
Vd none

Drug Interactions

Drug / Agent Mechanism Severity
warfarin, digoxin, lithium reduced absorption of orally administered drugs if taken simultaneously moderate
diabetes medications reduced postprandial glucose absorption may require adjustment minor

Nursing Considerations

  1. Always administer with at least 8 oz (240 mL) of water to prevent esophageal and GI obstruction.
  2. Separate administration from other oral medications by at least 2 hours to avoid impaired drug absorption.
  3. Start with lower doses and titrate gradually to minimize GI bloating and gas during the first 1–2 weeks.
  4. Educate patients with diabetes that psyllium reduces postprandial glucose spikes, which may require monitoring of blood glucose.

Clinical Pearls

  • Psyllium is the only FDA-approved fiber supplement with an approved cardiovascular disease risk-reduction claim, as studies demonstrate up to 10–15% reduction in LDL cholesterol.
  • Unlike stimulant laxatives, psyllium is safe for chronic long-term use and is appropriate for elderly patients with chronic constipation.

Safety Profile

Pregnancy safe
Lactation generally-safe
Renal Adjustment Not required
Hepatic Adjustment Not required
TDM Not required